Search clinical trials for: H3 K27-altered
Total 124 results
-
Teva Branded Pharmaceutical Products R&D, Inc.CompletedRelapsing-Remitting Multiple SclerosisUnited States
-
Massachusetts General HospitalBeth Israel Deaconess Medical Center; Mclean HospitalCompleted
-
Ain Shams UniversityNasr City Insurance HospitalCompleted
-
KU LeuvenUnknownConcentration-Time Profiles in Stomach & Intestine.Belgium
-
Johnson & Johnson Consumer and Personal Products...CompletedNasal CongestionUnited States
-
NeurognosticsTerminatedRelapsing-Remitting Multiple SclerosisUnited States
-
University of Maryland, BaltimoreCompletedRenal Insufficiency, Chronic | Hepatitis C | Disorder of Transplanted KidneyUnited States
-
Jazz PharmaceuticalsCompletedMultiple Sclerosis | Neuropathic PainUnited Kingdom
-
Laboratorios Andromaco S.A.Completed
-
University of California, Los AngelesUniversity of Illinois at ChicagoCompletedMental Health Disorder | Developmental DelayUnited States
-
Federico II UniversityCompletedOverweight | HyperlipidemiaGreece, Hungary, Italy, Spain
-
Sanofi Pasteur, a Sanofi CompanyCompleted
-
Sanofi Pasteur, a Sanofi CompanyCompletedHealthy Volunteers | Influenza ImmunisationUnited States
-
Crystal Mackall, MDRecruitingBrain and Nervous SystemUnited States
-
ChimerixRecruitingGlioma | H3 K27MUnited States, Australia, Canada, Spain, Switzerland, Israel, Germany, Italy, United Kingdom, Korea, Republic of, Netherlands, Denmark, Austria
-
DT MedTech, LLCRecruitingOsteoarthritis Ankle | Post-Traumatic Osteoarthritis of Ankle | Osteoarthritis of Ankle Secondary to Inflammatory Arthritis (Disorder)United States
-
PersonGen BioTherapeutics (Suzhou) Co., Ltd.RecruitingRelapsed/Refractory Acute Myeloid LeukemiaChina
-
St. Jude Children's Research HospitalRecruitingGlioblastoma | Central Nervous System Neoplasms | High Grade Glioma | Ependymoma | Medulloblastoma | Diffuse Midline Glioma, H3 K27M-Mutant | Atypical Teratoid/Rhabdoid TumorUnited States
-
Sabine Mueller, MD, PhDNational Cancer Institute (NCI); Dana-Farber Cancer Institute; Mithil Prasad... and other collaboratorsRecruitingGlioblastoma | Recurrent Ependymoma | CNS Tumor | Diffuse Midline Glioma (DMG) | Recurrent Malignant Central Nervous System Neoplasm | Spinal Cord Glioma | Central Nervous System Tumor | World Health Organization (WHO) Grade III GliomaUnited States, Switzerland
-
Beijing Tiantan HospitalRecruiting
-
GlaxoSmithKlineTerminatedNarcolepsySpain, Germany, Netherlands, Austria, Finland, United Kingdom
-
H3 Biomedicine Inc.Eisai Inc.CompletedLiver Neoplasms | Hepatocellular Carcinoma | Advanced Hepatocellular Carcinoma | Liver Cancer | Hepatic Cancer | Hepatic CarcinomaFrance, United States, Belgium, Spain, Taiwan, Korea, Republic of, Russian Federation, Canada, Italy, Singapore, United Kingdom
-
Eisai Inc.H3 Biomedicine Inc.TerminatedLymphoma | Advanced Solid TumorsUnited States, Spain, France, Korea, Republic of, United Kingdom
-
UNC Lineberger Comprehensive Cancer CenterNot yet recruitingPancreas Cancer | Relapse | Resistant CancerUnited States
-
The First People's Hospital of LianyungangNot yet recruiting
-
Eisai Inc.H3 Biomedicine Inc.Withdrawn
-
Eisai Inc.H3 Biomedicine Inc.Completed
-
PersonGen BioTherapeutics (Suzhou) Co., Ltd.Tianjin Medical University Cancer Institute and Hospital; Shandong Cancer Hospital...RecruitingB7-H3-positive Relapsed/ Refractory NeuroblastomaChina
-
Second Affiliated Hospital of Soochow UniversitySoochow T-Maximun Biotechnology Co. LTDRecruitingAdvanced Glioma | Complication of Chimeric Antigen Receptor (CAR-T) Cell TherapyChina
-
MacroGenicsTerminatedMelanoma | Soft Tissue Sarcoma | Clear Cell Renal Cell Carcinoma | Breast Cancer | Pancreatic Cancer | Ovarian Cancer | Prostate Cancer | Non Small Cell Lung Cancer | Mesothelioma | Squamous Cell Carcinoma of the Head and Neck | Bladder Cancer | Colon Cancer | Thyroid CancerUnited States, Australia, Canada
-
Revalesio CorporationCompleted
-
GlaxoSmithKlineCompletedDementia | Mild Cognitive ImpairmentCanada
-
Sohag UniversityCompleted
-
UNC Lineberger Comprehensive Cancer CenterBellicum PharmaceuticalsNot yet recruitingBreast Cancer | Triple Negative Breast Cancer | Relapse | Resistant CancerUnited States
-
Centre Leon BerardActive, not recruitingPancreas AdenocarcinomaFrance
-
German Cancer Research CenterCharite University, Berlin, Germany; Roche Pharma AG; Johannes Gutenberg University... and other collaboratorsRecruitingNewly Diagnosed H3-mutated GliomaGermany
-
Peking UniversityRecruitingConditions or Focus of Study: B7-H3 Positive Relapsed/Advanced Malignant Solid TumorChina
-
Northwestern UniversityUniversity of Chicago; Purdue University; Agency for Healthcare Research and... and other collaboratorsCompleted
-
SUNHO（China）BioPharmaceutical CO., Ltd.RecruitingAdvanced Malignant TumorsChina
-
Corporación de Rehabilitación Club de Leones Cruz...Completed
-
PersonGen BioTherapeutics (Suzhou) Co., Ltd.RecruitingRelapsed/Refractory Acute Myeloid LeukemiaChina
-
AstraZenecaCompletedBrain Distribution of [11C]AZ12807110 and AZD5213Sweden
-
MacroGenicsTerminatedMelanoma | Non Small Cell Lung Cancer | Squamous Cell Carcinoma of Head and Neck | Triple Negative Breast Cancer | Metastatic Castrate Resistant Prostate Cancer | Advanced Solid Tumor, AdultSpain, United States, Australia, Poland
-
ChimerixActive, not recruitingDiffuse Intrinsic Pontine Glioma | Glioma, MalignantUnited States
-
MacroGenicsCompletedMelanoma | Non Small Cell Lung CancerUnited States
-
Peking University People's HospitalShanghai Hansen Biopharmaceutical Technology Co., Ltd; MEDx Translational Medicine...RecruitingProgression | Osteosarcoma | Surveillance | BiomarkerChina
-
Bispebjerg HospitalCompleted
-
Second Affiliated Hospital of Guangzhou Medical...Guangdong Zhaotai InVivo Biomedicine Co. Ltd.RecruitingBreast Cancer | Lung Cancer | Brain Tumor | Colo-rectal Cancer | Liver Cancer | Solid Tumor, Adult | CTLA4 | PD1China
-
Shenzhen Geno-Immune Medical InstituteSun Yat-sen University; Shenzhen Children's HospitalRecruiting
-
MacroGenicsMassachusetts General HospitalTerminated